Hyung Soo Ann

Title: Hyung Soo Ann: Innovator in Pharmaceutical Composition

Introduction

Hyung Soo Ann is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance therapeutic efficacy while minimizing adverse effects.

Latest Patents

Hyung Soo Ann holds a patent for a pharmaceutical composition comprising ticlopidine and Ginkgo biloba extract. This innovative formulation serves as an anti-thrombotic preparation, utilizing the combined PAF-antagonistic and anti-oxidant properties of both components. The invention aims to naturally suppress neutropenia and agranulocytosis, which are often caused by the toxicity associated with the repeated use of ticlopidine alone. This patent highlights his commitment to improving patient outcomes through innovative solutions.

Career Highlights

Hyung Soo Ann is associated with Yuyu International Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a focus on creating effective pharmaceutical solutions that address critical health issues.

Collaborations

Some of his notable coworkers include Hye Sook Yun-Choi and Yeong Shik Kim, who contribute to the collaborative environment at Yuyu International Co., Ltd. Their combined expertise fosters innovation and drives the development of new pharmaceutical products.

Conclusion

Hyung Soo Ann's contributions to pharmaceutical innovation, particularly through his patent on ticlopidine and Ginkgo biloba extract, exemplify his dedication to enhancing therapeutic practices. His work continues to impact the field positively, paving the way for future advancements in medicine.